Women's awareness and knowledge of hormone therapy post-Women's Health Initiative

Menopause

Volumn 14, Issue 5, 2007, Pages 853-858

  Rigby, Alison J ^a   Ma, Jun ^a   Stafford, Randall S ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hormone therapy; Menopause; Women's Health Initiative

Indexed keywords

ADULT; AFRICAN AMERICAN; AMNESIA; AWARENESS; BREAST CANCER; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HEALTH SURVEY; HORMONAL THERAPY; HUMAN; INTERNET; KNOWLEDGE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MENOPAUSE; OSTEOPOROSIS; OUTCOME ASSESSMENT; OUTCOMES RESEARCH; POPULATION RESEARCH; PUBLICATION; REVIEW; RISK; RISK BENEFIT ANALYSIS; SCORING SYSTEM; UNITED STATES; WOMEN'S HEALTH;

ADULT; BREAST NEOPLASMS; CARDIOVASCULAR DISEASES; COGNITION DISORDERS; COLONIC NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HEALTH BEHAVIOR; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFORMATION DISSEMINATION; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; QUESTIONNAIRES; RESEARCH DESIGN; SOCIOECONOMIC FACTORS; UNITED STATES; WOMEN'S HEALTH;

EID: 34948881694     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e3180333a33     Document Type: Review

References (18)

1. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principle results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-333.
2. US Preventive Services Task Force. Postmenopausal hormone replacement therapy for primary prevention of chronic conditions: recommendations and rationale. Ann Intern Med 2002;137:834-839.
3. The North American Menopause Society. Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society. Menopause 2004;11:11-33.
4. The North American Menopause Society. Recommendations for estrogen and progestogen use in peri- and postmenopausal women: October 2004 position statement of The North American Menopause Society. Menopause 2004;11:589-600.
5. Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004;291:1701-1712.
6. Hersh AL, Stefanick ML, Stafford RS. National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA 2004;291:47-53.
7. Breslau ES, Davis WW, Doner L, et al. The hormone therapy dilemma. J Am Med Womens Assoc 2003;58:33-43.
8. Bilgrami I, Blower K, Feng J, Stefanko G, Tan E. Changes in the use of hormone replacement therapy in New Zealand following the publication of the Women's Health Initiative trial. N Z Med J 2004;117:U1175.
9. Ettinger B, Grady D, Tosteson A, Pressman A, Macer JL. Effect of the Women's Health Initiative on women's decisions to discontinue postmenopausal hormone therapy. Obstet Gynecol 2003;102:1225-1232.
10. Ma J, Drieling R, Stafford RS. US women desire greater professional guidance on alternative therapies for relief of menopause symptoms. Menopause 2006;13:506-511.
11. Majumdar SR, Almasi E, Stafford RS. Promotion and prescribing of hormone therapy after report of harm by the Women's Health Initiative. JAMA 2004;292:1983-1988.
12. Austin PC, Mamdani MU, Tun K, Jaakkimainen L. Prescriptions for estrogen replacement therapy in Ontario before and after publication of the Women's Health Initiative study. JAMA 2003;289:3241-3242.
13. Heitmann C, Greiser E, Doren M. The impact of the Women's Health Initiative randomized controlled trial 2002 on perceived risk communication and use of hormone therapy in Germany. Menopause 2005;12:405-411.
14. Buist DSM, Newton KM, Miglioretti DL, et al. Hormone therapy prescribing patterns in the United States. Obstet Gynecol 2004;104:1042-1050.
15. Levens E, Williams RS. Current opinions and understandings of menopausal women after hormone replacement therapy - the University of Florida experience. Am J Obstet Gynecol 2004;191:641-647.
16. Schronberg MA, Davis RB, Wee CC. After the Women's Health Initiative: decision making and trust of women taking hormone therapy. Womens Health Issues 2005;15:187-195.
17. Agency for Healthcare Research and Quality. 2004 National Healthcare Disparities Report. Rockville, MD: US Department of Health and Human Services, 2004. AHQR publication no. 05-0014. Available at: http://www.ahgr.gov/ qual/nhdr04/nhdr2004.pdf.
18. Couper M. Web surveys: a review of issues and approaches. Public Opin Q 2000;64:464-494.